的第一次部署一个便携式的床边,低场磁共振成像解决方案基于人工智能的应用(2771)
做出评论
看到评论

文摘
摘要目的:为便携式展示概念,床边磁共振成像(MRI)在急性脑损伤使用基于人工智能(AI)测定质量效应(我)。
背景:轨迹MRI需要运输的患者为数据采集成像套件。低场核磁共振的进步使人们有可能获得有用的成像在床边。而人类读者评估中线移位(MS)是一种传统的质量效应(我)在脑损伤,这里我们使用基于便携式核磁共振大脑的三维图像使用人工智能评估质量效应。
设计/方法:我们研究了66名急性脑损伤患者承认一位重症监护室接受便携式64吨核磁共振在床边。三个人类注释器标志着中线的转变在t2加权或稳态自由旋进(SSFP)序列在镰,隔膜,松果体。深入学习模式应用在TensorFlow使用U-Net神经网络和实施。基线使用美国国立卫生研究院的中风尺度损伤严重程度评分(署)和功能结果在放电获得的医疗记录。在Python中执行统计分析。做了相关分析之间的个人和human-MS与AI-ME的平均分数。对署Human-MS和AI-ME相关。
结果:平均与AI-ME human-MS相关(p = 0.01)。平均9 human-MS措施必须达到相关的显著性水准AI-ME,然而。个人human-MS评级也相关,但不显著(p = 0.03)。个人human-MS措施没有关联署(p = 0.55)。平均human-MS和AI-ME显示趋势相关性署(分别为p = 0.11, p = 0.07)。
结论:这些数据表明使用便携式核磁共振装置在急性脑损伤患者床边。便携式图像先生可以确定和解释等临床相关成果质量效应利用人工智能方法,独立于人类的读者。
披露:Sheth博士已经收到版税、许可费或合同权利支付从阿尔瓦的健康。Sheth博士持有股票或股票期权在阿尔瓦卫生赞助研究Sheth博士参与作为一个侦探。Sheth博士已经收到了从超精细研究支持,诺华,生原体,巴德,关税。卡恩博士没有披露。萨利希博士已经收到个人赔偿咨询、担任科学顾问委员会说,与超精细或其他活动。沙阿博士收到超精细研究,研究支持Inc.Dr。已收到个人赔偿咨询、担任科学顾问委员会说,与超精细研究或其他活动,Inc .博士持有股票或股票期权的超精细研究,Inc .韦尔奇博士已经收到个人赔偿咨询、担任科学顾问委员会说,与超精细研究或其他活动,公司. .韦尔奇博士持有股票或股票期权的超精细研究,Inc . Sofka博士已经收到个人赔偿咨询、担任科学顾问委员会说,与超精细或其他活动。Sacolick博士已经收到个人赔偿咨询、担任科学顾问委员会说,与超精细研究或其他活动,公司. .Sacolick博士持有股票或股票期权的超精细研究,Inc .袁博士收到超精细研究,研究支持Inc . Mazurek博士收到超精细研究,研究支持公司Matouk博士没有披露。 Dr. Gordon has nothing to disclose. Dr. Ward has nothing to disclose. Dr. Payabvash has nothing to disclose. Dr. Falcone has nothing to disclose. Dr. Petersen has nothing to disclose. Dr. Schindler has nothing to disclose. Dr. Gilmore has nothing to disclose. Dr. Hwang has nothing to disclose. Dr. Gobeske has nothing to disclose. Dr. Kim has nothing to disclose. Dr. Sansing has nothing to disclose. Dr. Sze has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Hyperfine. Dr. Sze has received research support from Hyperfine. Dr. Rosen has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Hyperfine Research, Inc. Dr. Rosen has received royalty, license fees, or contractual rights payments from BlinkAI. Dr. Rosen holds stock and/or stock options in BlinkAI. Dr. Rosen has received research support from GE Healthcare. Dr. Kimberly has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Biogen. Dr. Kimberly has received research support from Biogen. Dr. Kundu has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Hyperfine.
信:快速的网络通信
你可能也会感兴趣
相关文章
-
没有找到相关文章。